XML 38 R27.htm IDEA: XBRL DOCUMENT v3.25.3
Segments (Tables)
9 Months Ended
Sep. 30, 2025
Segments [Abstract]  
Segment Data Segment data for the three months ending September 30, 2025 are as follows (in thousands):

Reportable

Chemed

VITAS

Roto-Rooter

Segments

Corporate

Consolidated

Service revenues and sales

$

407,741 

$

217,159 

$

624,900 

$

-

$

624,900 

Cost of services provided and goods sold

(excluding depreciation)

Wages

239,357 

72,992 

312,349 

-

312,349 

Patient care expense

43,269 

-

43,269 

-

43,269 

Other expenses

38,239 

34,136 

72,375 

-

72,375 

Total cost of services provided and goods sold

320,865 

107,128 

427,993 

-

427,993 

Selling, general and administrative expense

Wages

16,904 

21,122 

38,026 

6,440 

44,466 

Advertising

-

19,542 

19,542 

-

19,542 

Stock compensation

-

-

-

5,851 

5,851 

Other expenses

8,332 

20,008 

28,340 

7,576 

35,916 

Total selling, general and administrative expense

25,236 

60,672 

85,908 

19,867 

105,775 

Depreciation

5,354 

8,298 

13,652 

12 

13,664 

Amortization

26 

2,544 

2,570 

-

2,570 

Other operating expense/(income)

186 

(38)

148 

-

148 

Total costs and expenses

351,667 

178,604 

530,271 

19,879 

550,150 

Income/(loss) from operations

56,074 

38,555 

94,629 

(19,879)

74,750 

Interest expense

(56)

(132)

(188)

(269)

(457)

Intercompany interest income/(expense)

5,685 

4,030 

9,715 

(9,715)

-

Other income - net

61 

25 

86 

9,165 

9,251 

Income/(expense) before income taxes

61,764 

42,478 

104,242 

(20,698)

83,544 

Income taxes

(14,993)

(10,407)

(25,400)

6,093 

(19,307)

Net income/(loss)

$

46,771 

$

32,071 

$

78,842 

$

(14,605)

$

64,237 

Additions to long-lived assets

$

10,850 

$

6,639 

$

17,489 

$

10 

$

17,499 


Segment data for the three months September 30, 2024 are as follows (in thousands):

Reportable

Chemed

VITAS

Roto-Rooter

Segments

Corporate

Consolidated

Service revenues and sales

$

391,406 

$

214,775 

$

606,181 

$

-

$

606,181 

Cost of services provided and goods sold

(excluding depreciation)

Wages

222,868 

70,078 

292,946 

-

292,946 

Patient care expense

37,188 

-

37,188 

-

37,188 

Other expenses

34,880 

31,173 

66,053 

-

66,053 

Total cost of services provided and good sold

294,936 

101,251 

396,187 

-

396,187 

Selling, general and administrative expense

Wages

17,658 

18,979 

36,637 

3,643 

40,280 

Advertising

-

18,420 

18,420 

-

18,420 

Stock compensation

-

-

-

9,121 

9,121 

Other expenses

8,225 

19,673 

27,898 

6,262 

34,160 

Total selling, general and administrative expense

25,883 

57,072 

82,955 

19,026 

101,981 

Depreciation

5,063 

8,071 

13,134 

13 

13,147 

Amortization

26 

2,524 

2,550 

-

2,550 

Other operating expense/(income)

97 

62 

159 

-

159 

Total costs and expenses

326,005 

168,980 

494,985 

19,039 

514,024 

Income/(loss) from operations

65,401 

45,795 

111,196 

(19,039)

92,157 

Interest expense

(46)

(114)

(160)

(267)

(427)

Intercompany interest income/(expense)

4,920 

3,656 

8,576 

(8,576)

-

Other income - net

62 

18 

80 

9,219 

9,299 

Income/(expense) before income taxes

70,337 

49,355 

119,692 

(18,663)

101,029 

Income taxes

(16,851)

(11,400)

(28,251)

2,998 

(25,253)

Net income/(loss)

$

53,486 

$

37,955 

$

91,441 

$

(15,665)

$

75,776 

Additions to long-lived assets

$

7,768 

$

10,778 

$

18,546 

$

100 

$

18,646 


Segment data for the nine months September 30, 2025 are as follows (in thousands):

Reportable

Chemed

VITAS

Roto-Rooter

Segments

Corporate

Consolidated

Service revenues and sales

$

1,211,341 

$

679,300 

$

1,890,641 

$

-

$

1,890,641 

Cost of services provided and goods sold

(excluding depreciation)

Wages

716,335 

226,168 

942,503 

-

942,503 

Patient care expense

124,656 

-

124,656 

-

124,656 

Other expenses

113,325 

112,144 

225,469 

-

225,469 

Total cost of services provided and goods sold

954,316 

338,312 

1,292,628 

-

1,292,628 

Selling, general and administrative expense

Wages

51,188 

63,326 

114,514 

13,919 

128,433 

Advertising

-

56,654 

56,654 

-

56,654 

Stock compensation

-

-

-

27,668 

27,668 

Other expenses

25,673 

63,876 

89,549 

9,381 

98,930 

Total selling, general and administrative expense

76,861 

183,856 

260,717 

50,968 

311,685 

Depreciation

15,863 

24,899 

40,762 

36 

40,798 

Amortization

78 

7,635 

7,713 

-

7,713 

Other operating expense/(income)

305 

(80)

225 

-

225 

Total costs and expenses

1,047,423 

554,622 

1,602,045 

51,004 

1,653,049 

Income/(loss) from operations

163,918 

124,678 

288,596 

(51,004)

237,592 

Interest expense

(150)

(394)

(544)

(685)

(1,229)

Intercompany interest income/(expense)

16,436 

11,930 

28,366 

(28,366)

-

Other income - net

170 

58 

228 

13,742 

13,970 

Income/(expense) before income taxes

180,374 

136,272 

316,646 

(66,313)

250,333 

Income taxes

(45,353)

(32,344)

(77,697)

15,851 

(61,846)

Net income/(loss)

$

135,021 

$

103,928 

$

238,949 

$

(50,462)

$

188,487 

Additions to long-lived assets

$

22,234 

$

24,825 

$

47,059 

$

15 

$

47,074 


Segment data for the nine months September 30, 2024 are as follows (in thousands):

Reportable

Chemed

VITAS

Roto-Rooter

Segments

Corporate

Consolidated

Service revenues and sales

$

1,119,970 

$

671,324 

$

1,791,294 

$

-

$

1,791,294 

Cost of services provided and goods sold

(excluding depreciation)

Wages

639,103 

221,669 

860,772 

-

860,772 

Patient care expense

108,887 

-

108,887 

-

108,887 

Other expenses

104,357 

97,048 

201,405 

-

201,405 

Total cost of services provided and goods sold

852,347 

318,717 

1,171,064 

-

1,171,064 

Selling, general and administrative expense

Wages

51,556 

60,056 

111,612 

11,950 

123,562 

Advertising

-

55,271 

55,271 

-

55,271 

Stock compensation

-

-

-

39,730 

39,730 

Other expenses

22,412 

60,356 

82,768 

18,778 

101,546 

Total selling, general and administrative expense

73,968 

175,683 

249,651 

70,458 

320,109 

Depreciation

15,288 

24,275 

39,563 

38 

39,601 

Amortization

79 

7,538 

7,617 

-

7,617 

Other operating expense

160 

128 

288 

-

288 

Total costs and expenses

941,842 

526,341 

1,468,183 

70,496 

1,538,679 

Income/(loss) from operations

178,128 

144,983 

323,111 

(70,496)

252,615 

Interest expense

(138)

(349)

(487)

(794)

(1,281)

Intercompany interest income/(expense)

15,096 

10,638 

25,734 

(25,734)

-

Other income - net

138 

64 

202 

27,806 

28,008 

Income/(expense) before income taxes

193,224 

155,336 

348,560 

(69,218)

279,342 

Income taxes

(46,517)

(36,010)

(82,527)

14,865 

(67,662)

Net income/(loss)

$

146,707 

$

119,326 

$

266,033 

$

(54,353)

$

211,680 

Additions to long-lived assets

$

104,337 

$

29,800 

$

134,137 

$

271 

$

134,408 

Identifiable Assets By Segment

September 30,

December 31,

2025

2024

VITAS

$

822,484 

$

839,568 

Roto-Rooter

535,182 

529,076 

Reportable segments

1,357,666 

1,368,644 

Corporate

265,953 

299,931 

Chemed consolidated

$

1,623,619 

$

1,668,575